Form 4: TG Therapeutics CEO Transfers Over 4.6M Shares to Trusts

TG Therapeutics CEO Michael S. Weiss reported the transfer of 4,668,843 shares of common stock to family trusts for estate planning purposes.

Summary

• Michael S. Weiss, CEO and Director of TG Therapeutics, Inc. (TGTX), reported changes in his beneficial ownership of common stock.
• On November 5, 2025, Mr. Weiss disposed of 3,865,126 shares of common stock, which was a distribution upon the termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of his children.
• On the same date, an additional 803,717 shares of common stock were transferred to The Weiss Family and Descendants Trust.
• Both transactions were reported with a price of $0, indicating they were transfers or gifts rather than market sales.
• Following these reported transactions, Mr. Weiss beneficially owns 9,156,086 shares of common stock, which includes shares of restricted common stock vesting over various time periods.

Sentiment

Score: 5

Explanation: The filing reports administrative transfers of shares for estate planning purposes, which are neutral in terms of company performance or outlook.

Future Outlook

NA

Management Comments

• The disposition of 3,865,126 shares represents a distribution upon termination of the Michael Sean Weiss 2022 Grantor Retained Annuity Trust to irrevocable trusts for the benefit of Mr. Weiss' children.
• The transfer of 803,717 shares represents a transfer to The Weiss Family and Descendants Trust.
• Beneficial ownership following transactions includes shares of restricted Common Stock, which vest over various time periods.

Industry Context

This filing reports an insider transaction related to personal estate planning and does not directly reflect on broader industry trends or competitive positioning.

Related Party Transactions

• Disposition of 3,865,126 shares to irrevocable trusts for the benefit of Mr. Weiss' children.
• Transfer of 803,717 shares to The Weiss Family and Descendants Trust.

Stakeholder Impact

• Shareholders: Minimal direct impact as these are non-market transfers for estate planning and do not reflect a change in management's operational outlook or confidence in the company.

Key Dates

Keywords

TGTX, Michael S. Weiss, Form 4, Insider Transaction, Share Transfer, Estate Planning, CEO, Director, Beneficial Ownership